Trial Profile
Cardiac safety study of sofosbuvir-based regimens in HCV infected patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 14 Nov 2017 New trial record
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases